| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |